Valuation: Becton, Dickinson and Company

Market Cap 4.56TCr 3.97TCr 3.69TCr 3.39TCr 6.4TCr 4,35600Cr 6.5TCr 44TCr 17TCr 2,16900Cr 17TCr 17TCr 7,27200Cr P/E 2026 *
36.1x
P/E 2027 * 23.5x
Enterprise Value 6.18TCr 5.37TCr 5TCr 4.59TCr 8.67TCr 5,90200Cr 8.81TCr 59TCr 23TCr 2,93800Cr 23TCr 23TCr 9,85300Cr EV / Sales 2026 *
3.22x
EV / Sales 2027 * 3.01x
Free-Float
74.04%
Yield 2026 *
2.37%
Yield 2027 * 2.4%
1 day-2.60%
1 week+7.51%
1 month+9.55%
3 months+14.66%
6 months-14.87%
Current year-13.05%
1 week 137
Extreme 137
147.8
1 month 131.3
Extreme 131.3
147.8
Current year 121
Extreme 121
179
1 year 121
Extreme 121
179
3 years 121
Extreme 121
261
5 years 121
Extreme 121
265
10 years 121
Extreme 121
265
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.60%+7.51% - - 4.56TCr
+0.09%+2.56%-16.96%-4.37% 18TCr
-0.37%+2.62%-4.42%-2.61% 11TCr
-0.29%+0.47%+7.97%+64.64% 6.06TCr
+3.50%+0.47%+41.00%+46.44% 5.18TCr
+0.41%+1.37% - - 3.32TCr
+11.95%+16.65%+5.26%-31.60% 3.15TCr
+0.40%+3.89%+42.51%-8.26% 2.4TCr
-1.22%+6.69%+0.67%+1.96% 2.23TCr
-3.79%+7.37%-9.34%-0.68% 2.15TCr
Average +0.81%+5.02%+8.34%+8.19% 5.97TCr
Weighted average by Cap. +0.54%+3.44%+0.04%+8.08%

Financials

2026 *2027 *
Net sales 1.92TCr 1.67TCr 1.55TCr 1.43TCr 2.7TCr 1,83400Cr 2.74TCr 18TCr 7.19TCr 91TCr 7.22TCr 7.06TCr 3,06200Cr 1.97TCr 1.71TCr 1.6TCr 1.47TCr 2.77TCr 1,88300Cr 2.81TCr 19TCr 7.38TCr 94TCr 7.41TCr 7.24TCr 3,14300Cr
Net income 128.97Cr 112.11Cr 104.35Cr 96Cr 180.93Cr 12TCr 183.73Cr 1.23TCr 482.76Cr 6.13TCr 484.36Cr 473.72Cr 21TCr 197.54Cr 171.72Cr 159.83Cr 146.75Cr 277.12Cr 19TCr 281.41Cr 1.88TCr 739.42Cr 9.39TCr 741.87Cr 725.57Cr 31TCr
Net Debt 1.62TCr 1.41TCr 1.31TCr 1.2TCr 2.27TCr 1,54600Cr 2.31TCr 15TCr 6.06TCr 77TCr 6.08TCr 5.95TCr 2,58100Cr 1.38TCr 1.2TCr 1.12TCr 1.03TCr 1.94TCr 1,31900Cr 1.97TCr 13TCr 5.17TCr 66TCr 5.19TCr 5.07TCr 2,20200Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
31/26/31 €143.95 -2.60% 0
30/26/30 €147.80 +1.93% 20
29/26/29 €145.00 +3.68% 160
28/26/28 €139.85 +2.08% 0
27/26/27 €137.00 +2.32% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
165.62USD
Average target price
180.25USD
Spread / Average Target
+8.83%

Quarterly revenue - Rate of surprise